![Tony Nguyen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tony Nguyen
Direttore/Membro del Consiglio presso Visus Therapeutics, Inc.
Posizioni attive di Tony Nguyen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Visus Therapeutics, Inc.
![]() Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Direttore/Membro del Consiglio | - | - |
RTW Investments /Venture/
![]() RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Investitore di Private Equity | 01/07/2019 | - |
Storia della carriera di Tony Nguyen
Formazione di Tony Nguyen
National University of Singapore | Undergraduate Degree |
St. John's University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Singapore | 2 |
Posizioni
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Director/Board Member | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Visus Therapeutics, Inc.
![]() Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Health Technology |
RTW Investments /Venture/
![]() RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Finance |
- Borsa valori
- Insiders
- Tony Nguyen
- Esperienza